Plexus Corp. (NASDAQ:PLXS – Get Free Report) CEO Todd Kelsey sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $274.75, for a total transaction of $274,750.00. Following the completion of the sale, the chief executive officer directly owned 71,388 shares in the company, valued at approximately $19,613,853. This trade represents a 1.38% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Plexus Stock Performance
Shares of NASDAQ PLXS traded up $0.47 during midday trading on Friday, hitting $268.36. The company’s stock had a trading volume of 336,736 shares, compared to its average volume of 339,031. The stock has a fifty day moving average price of $236.35 and a 200 day moving average price of $194.02. Plexus Corp. has a one year low of $115.35 and a one year high of $275.83. The company has a current ratio of 1.54, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. The firm has a market capitalization of $7.18 billion, a price-to-earnings ratio of 39.23 and a beta of 0.88.
Plexus (NASDAQ:PLXS – Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.18. Plexus had a net margin of 4.35% and a return on equity of 12.84%. The company had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.13 billion. During the same quarter in the previous year, the firm posted $1.66 earnings per share. The company’s quarterly revenue was up 18.7% compared to the same quarter last year. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. On average, research analysts forecast that Plexus Corp. will post 5.98 EPS for the current fiscal year.
Institutional Trading of Plexus
Analyst Ratings Changes
Several equities research analysts have recently weighed in on the company. Needham & Company LLC upped their price target on Plexus from $206.00 to $285.00 and gave the company a “buy” rating in a research report on Friday, May 1st. Wall Street Zen raised shares of Plexus from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Benchmark reaffirmed a “buy” rating and set a $220.00 target price on shares of Plexus in a report on Monday, March 16th. Stifel Nicolaus set a $280.00 target price on shares of Plexus in a research note on Tuesday. Finally, Zacks Research downgraded shares of Plexus from a “hold” rating to a “strong sell” rating in a report on Wednesday, May 20th. Five analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $234.17.
Read Our Latest Report on PLXS
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Further Reading
- Five stocks we like better than Plexus
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
